Platelet Function Profile Post-Clopidogrel Therapy in Patients With Type 2 Diabetes Undergoing Coronary Stent Implantation (Q46358660)

21 December 2017

title

Platelet function profile post-clopidogrel therapy in patients with type 2 diabetes undergoing coronary stent implantation (English)

1 reference

21 December 2017

Platelet Function Profile Post-Clopidogrel Therapy in Patients With Type 2 Diabetes Undergoing Coronary Stent Implantation (English)

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

19 December 2024

Abeer Attia Saad

1

1 reference

21 December 2017

Eman Abdel Rahman Ismail

2

1 reference

21 December 2017

Yasser Wagih Darwish

3

1 reference

21 December 2017

Hesham Ahmed Nasr

4

1 reference

21 December 2017

Abdel Rahman Hassan

5

1 reference

21 December 2017

Ibrahim Bedeer

6

1 reference

21 December 2017

Marian Adel Alfons

7

1 reference

21 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22146578

19 December 2024

publication date

5 December 2011

1 reference

21 December 2017

Clinical and Applied Thrombosis-Hemostasis

published in

1 reference

21 December 2017

volume

18

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

249-257

1 reference

21 December 2017

Platelet activation in myocardial ischemic syndromes

cites work

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Role of platelets in the pathophysiology of acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

The role of platelet receptors and adhesion molecules in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

The platelet in diabetes: focus on prevention of ischemic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Platelet activation in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Platelet purinergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Identification of the platelet ADP receptor targeted by antithrombotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Central role of the P2Y12 receptor in platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Narrative review: aspirin resistance and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Clinical importance of aspirin and clopidogrel resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Clinical Value of Antiplatelet Therapy in Patients with Acute Coronary Syndromes and in Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Resistance to aspirin and clopidogrel therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Monitoring of clopidogrel action: comparison of methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Clopidogrel resistance: a new chapter in a fast-moving story

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

The difference between clopidogrel responsiveness and posttreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Diabetes mellitus as a prothrombotic condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Correlation between cardiovascular disease and diabetes mellitus: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Enhanced post-clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Poor response to clopidogrel: current and future options for its management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Clopidogrel Resistance is Associated with Long-Term Thrombotic Events in Patients Implanted with Drug-Eluting Stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Light transmittance aggregometry induced by different concentrations of adenosine diphosphate to monitor clopidogrel therapy: a methodological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Reducing intra-individual variation in platelet aggregation: implications for platelet function testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Evaluation of platelet membrane glycoproteins in coronary artery disease : consequences for diagnosis and therapy

21 January 2018

39

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study

19 December 2024

49

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

19 December 2024

50

67

623

Zurakowski A

2009

1 reference

https://api.crossref.org/works/10.1177/1076029611427899

19 December 2024

Identifiers

1 reference

21 December 2017

1 reference

21 December 2017